Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - CHANGE IN WORKING CAPITAL
Change in Working Capital REGN - Regeneron Pharmaceuticals, Inc.
-618 M
LAST VALUE
-59.41%
2 YEAR CAGR
-25.26%
5 YEAR CAGR
-41.22%
10 YEAR CAGR